[ad_1] Pharma Firm Gets HC Relief in Rs 64 Lakh NPPA Overpricing Row Over DOLOCIDE-MR We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Natco Gets SC Nod to Launch Generic Risdiplam at 80% Lower Price, Roche Appeal Dismissed We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Haryana-based Alchem International on Thursday moved the division bench of the Delhi High Court, challenging a single-judge’s decision restraining it from selling, manufacturing or dealing with any pharmaceutical product using the name ‘Alchem’, or any other name similar to Mumbai-based Alkem Laboratories‘ ‘Alkem’ trademark till further orders. A division bench comprising Justices C. Hari…
[ad_1] Sun Pharma Wins Interim Relief in NAXDOM Trademark Row, Delhi HC Bars Alenvision’s NEXADOM Drug We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Delhi HC Dismisses Roche Appeal, Allows Natco to Continue Selling Generic Risdiplam for Spinal Muscular Atrophy We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Delhi HC seeks Centre’s response on plea challenging PG medical seats allocation at AFMS We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Mumbai: In a landmark ruling, an appellate bench of the Delhi High Court on Wednesday sided with Hyderabad-based Natco Pharma over a long-drawn patent battle involving Swiss biotech giant Roche‘s rare disease drug risdiplam made available in India under the brand name Evrysdi. A leading expert on patents and intellectual property rights told ET…
[ad_1] A division bench of the Delhi High Court on Thursday allowed Natco Pharma to launch the drug risdiplam in India, even as it rejected Swiss multinational F. Hoffmann-La Roche AG’s plea seeking to the contrary. The bench led by Justice Hari Shankar vacated its March order that had asked Hyderabad-based Natco Pharma to maintain…
[ad_1] Mankind Pharma Secures Interim Injunction Against Biodiscovery Over Fendikind, Zenkind, Kind Trademarks We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Attacks on doctors threaten Lives and patient safety in Hospitals: Delhi HC Warns We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link